Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
5254.81%
operating margin TTM
4783.05%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.34 |
| peg ratio | 0.00 |
| price to book ratio | -1.57 |
| price to sales ratio | -102.81 |
| enterprise value multiple | -1.80 |
| price fair value | -1.57 |
profitability ratios | |
|---|---|
| gross profit margin | 195.64% |
| operating profit margin | 4783.05% |
| pretax profit margin | 5384.94% |
| net profit margin | 5254.81% |
| return on assets | -233.43% |
| return on equity | 222.01% |
| return on capital employed | 2230.6% |
liquidity ratios | |
|---|---|
| current ratio | 0.81 |
| quick ratio | 0.63 |
| cash ratio | 0.39 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,654.78 |
| operating cycle | 1,138.81 |
| days of payables outstanding | 2,233.47 |
| cash conversion cycle | -1,094.66 |
| receivables turnover | -0.71 |
| payables turnover | 0.16 |
| inventory turnover | 0.22 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.70 |
| debt equity ratio | -1.77 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 2.29 |
| interest coverage | -210.62 |
| cash flow to debt ratio | -3.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.24 |
| cash per share | 0.44 |
| operating cash flow per share | -2.24 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.10 |
| short term coverage ratios | -3.12 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Outlook Therapeutics, Inc. (NASDAQ:OTLK) reported earnings?
Outlook Therapeutics, Inc. (OTLK) published its most recent earnings results on 18-08-2026.
What is Outlook Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Outlook Therapeutics, Inc. (NASDAQ:OTLK)'s trailing twelve months ROE is 222.01%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Outlook Therapeutics, Inc. (OTLK) currently has a ROA of -233.43%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OTLK's net profit margin stand at?
OTLK reported a profit margin of 5254.81% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OTLK's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.81 in the most recent quarter. The quick ratio stood at 0.63, with a Debt/Eq ratio of -1.77.